By: Ranjini K
July 22 2020
Dr. Richard Bartlett uses a comparatively inexpensive asthma medicine budesonide to treat COVID-19 patients, but its success rate cannot be verified.
Dr. Richard Bartlett uses a comparatively inexpensive asthma medicine budesonide to treat COVID-19 patients, but its success rate cannot be verified.Dr.Richard Bartlett, a physician from Texas, prescribes to inhale corticosteroid medicine, Budesonide, to COVID-19 patients, which is a conventional treatment for Asthma. It is a respiratory anti-inflammatory medicine used to treat respiratory inflammatory disease. It is a generic medicine which inexpensive compared to the widely used treatment methods which are currently used all over the world. He claims that he is using this medicine since March. He further added that Taiwan, Singapore, and Japan had used this method, and the death rate in COVID-19 has decreased. However, the claim that it has a 100% success rate is unverifiable because Dr. Bartlett’s approach is a hypothesis that is not explored at the current time, and there is no enough evidence for it. The Centers for Disease Control and Prevention(CDC) has said that there is no known cure for the pandemic. The research & development blueprint by the World Health Organisation(WHO) aims to improve coordination between scientists and global health professionals, accelerate the research and development process. The researchers are investigating a variety of potential treatments for the COVID-19. The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.